The ROE as of September 2024 (TTM) for Aquestive Therapeutics, Inc. (AQST) is 36.59%

According to Aquestive Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 36.59%. This represents a change of 177.85% compared to the average of 13.17% of the last 4 quarters.

Aquestive Therapeutics, Inc. (AQST) Historical ROE (quarterly & annually)

How has AQST ROE performed in the past?

The mean historical ROE of Aquestive Therapeutics, Inc. over the last ten years is 121.11%. The current 36.59% ROE has changed -69.79% with respect to the historical average. Over the past ten years (40 quarters), AQST's ROE was at its highest in in the March 2019 quarter at 243.16%. The ROE was at its lowest in in the December 2018 quarter at -138.33%.

Aquestive Therapeutics, Inc. (AQST) ROE by Quarter and Year

Discovering the peaks and valleys of Aquestive Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aquestive Therapeutics, Inc. (AQST) Average ROE

How has AQST ROE performed in the past?

The current ROE of Aquestive Therapeutics, Inc. (AQST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Aquestive Therapeutics, Inc. (AQST) ROE vs. Peers

How is AQST’s ROE compared to its peers?

Aquestive Therapeutics, Inc.’s ROE is greater than Evoke Pharma, Inc. (-964.02%), less than Adamis Pharmaceuticals Corporation (0.93%), greater than Guardion Health Sciences, Inc. (-71.26%), greater than AcelRx Pharmaceuticals, Inc. (-48.62%), less than Dynavax Technologies Corporation (2.76%), less than Amphastar Pharmaceuticals, Inc. (25.42%), less than Lantheus Holdings, Inc. (49.15%), less than ANI Pharmaceuticals, Inc. (6.02%), greater than Ironwood Pharmaceuticals, Inc. (-2.78%), less than Alkermes plc (22.66%), less than Eagle Pharmaceuticals, Inc. (4.41%), greater than Shuttle Pharmaceuticals Holdings, Inc. (-217.58%), greater than Mallinckrodt plc (-117.04%), less than Agile Therapeutics, Inc. (104.04%), less than Lifecore Biomedical, Inc. (26.37%), greater than Organogenesis Holdings Inc. (-2.77%), greater than Lucy Scientific Discovery Inc. (-377.80%), greater than Alimera Sciences, Inc. (-33.70%),

Build a custom stock screener for Aquestive Therapeutics, Inc. (AQST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aquestive Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aquestive Therapeutics, Inc. (AQST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aquestive Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.